Loading the company…
Loading the company…
Families: Tumor ablation, Tumor & fibroid embolization.
All companies · Product and company coverage
In the last ten years FDA made 7 decisions for Varian Medical Systems (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 2 procedure families, the most in 2024 (3). The latest was on 2025-01-17.
| Family | Decisions on record |
|---|---|
| Tumor ablation | 5 |
| Tumor & fibroid embolization | 2 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2025-01-17 | 510(k) | K242608 | Embozene Color-Advanced Microspheres |
| 2024-10-16 | 510(k) | K242794 | ONCOZENE Microspheres |
| 2024-07-19 | 510(k) | K240480 | IntelliBlate Microwave Ablation System Console (IB-CON); IntelliBlate Microwave Ablation System Mobile Cart (IB-CART); IntelliBlate Ximitry Probe Assembly, 13G x 15cm (IB-XPA-1315); IntelliBlate Ximitry Probe Assembly, 13G x 20cm (IB-XPA-1320); IntelliBlate Ximitry Probe Assembly, 13G x 27cm (IB-XPA-1327) |
| 2024-05-29 | 510(k) | K240784 |
| Temperature Sensor Probe (ABL-18TP20) |
| 2023-03-28 | 510(k) | K230271 | ISOLIS Cryoprobe |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Varian Medical Systems.